Remove 2018 Remove FDA Remove Immunization
article thumbnail

Gaps Remain in MOUD Access Across Opioid Treatment Programs

Drug Topics

In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.

article thumbnail

Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable

Drug Topics

Approximately 31% of people in the United States were overweight and 42% were obese in 2017 to 2018, compared with 34% and 30.5% " Obesity has risen considerably over the past 3 years, according to data from the Pew Research Center. in 1999 to 2000, respectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

Similar to Phillips’ idea of planning ahead, the FDA also has detailed provisions for patients to take during power outages, floods, or other events that compromise their ability to manage their medications. “An Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote. from 1999 to 2018.

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Updated March 20, 2018. A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard-Robarts Collaboration. ClinicalTrials.gov identification: NCT00160108. Accessed June 12, 2025. Diet and Body Composition (CENTRAL). ClinicalTrials.gov identification: NCT01530724. Updated October 23, 2020. Accessed June 12, 2025.

article thumbnail

Steatosis Liver Disease Shows Increased Risk of Diabetes for Patients With Atrial Fibrillation

Drug Topics

The study investigators included patients who developed AF between January 1, 2010, and December 31, 2018, and were included in the National Health Insurance Service of South Korea. 1 Investigators included a total of 195,195 patients with AD, who had a mean age of 64.4 years and 57.5%

article thumbnail

EHA21: Sanofi builds case for rare disease drug sutimlimab after FDA rejection

pharmaphorum

Sanofi’s hopes of a speedy approval of first-in-class C1s inhibitor sutimlimab in rare disorder cold agglutinin disease (CAD) were dashed by the FDA, but new phase 3 data keep the drugmaker on track for a resubmission before year-end. Sutimlimab, which Sanofi acquired via its $11.6

FDA 97
article thumbnail

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Pharma Mirror

KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company’s track record as a premiere CDO service provider in the global market. Samsung Biologics (KRX: 207940.KS) We are extremely glad to.

FDA 52